FindTrial
Sign In

Microsatellite Alterations in Exhaled Breath Condensate from Patients with Non–Small Cell Lung Cancer

The clinical significance of detecting microsatellite alterations in 9p and 17q regions in Exhaled Breath Condensate from Patients with Non–Small Cell Lung Cancer

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-DDC-16008634
Enrollment
Unknown
Registered
2016-06-13
Start date
2013-08-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lung cancer

Interventions

Gold Standard:
Index test:

Sponsors

Songjiang Distric Central Hospital of Shanghai
Lead Sponsor

Eligibility

Sex/Gender
All
Age
47 Years to 74 Years

Inclusion criteria

Inclusion criteria: patient of non-small cell lung cancer at first diagnosis.

Exclusion criteria

Exclusion criteria: 1. No chemotherapy and no radiotherapy. 2. Small cell cancer patients.

Design outcomes

Primary

MeasureTime frame
D9S168;D9S171;D9S1604;D17S250;D17S855;D17S856;—

Countries

China

Contacts

Public ContactFan Li

Songjiang Distric Central Hospital of Shanghai

lifanking@live.com+86 021 67720302

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026